ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,025Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 917

$514K Total Retail Price of All Prescriptions

Rank: 112 out of 917

622 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 622 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 622 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 8,815 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 636 614 1 2
LISINOPRIL 528 509 2 1
ATENOLOL 445 415 3 12
OMEPRAZOLE 428 396 4 4
LOSARTAN POTASSIUM 390 346 5 13
HYDROCODONE-ACETAMINOPHEN 270 199 S3 6 6
AMLODIPINE BESYLATE 253 232 7 5
METFORMIN HCL 253 222 7 8
LEVOTHROID 223 200 9 94
HYDROCHLOROTHIAZIDE 219 207 10 9
K-TAB 216 208 11 111
FUROSEMIDE 197 176 12 7
WARFARIN SODIUM 197 179 12 10
METOPROLOL TARTRATE 177 163 14 11
GLIPIZIDE 151 129 15 40
NOVOLIN N 147 121 16 125
INSULIN SYRINGE 134 114 17 83
PRAVASTATIN SODIUM 124 113 18 20
ADACEL 117 111 19 131
LEVOTHYROXINE SODIUM 117 108 19 3
TRAZODONE HCL 114 108 21 22
FLUOXETINE HCL 112 94 22 38
FLUTICASONE PROPIONATE 110 101 23 26
MORPHINE SULFATE ER 110 80 S2 23 48
GABAPENTIN 105 89 25 17
NOVOLIN R 103 81 26 198
ATORVASTATIN CALCIUM 99 72 27 14
FAMOTIDINE 94 80 28 91
ALENDRONATE SODIUM 92 92 29 23
PROAIR HFA 91 84 30 35
TRIAMTERENE-HYDROCHLOROTHIAZID 90 83 31 147
OXYCODONE HCL 78 72 S2 32 27
OXYCODONE-ACETAMINOPHEN 72 46 S2 33 46
TAMSULOSIN HCL 71 66 34 25
ZOLPIDEM TARTRATE 69 40 35 21
ALLOPURINOL 66 58 36 31
CLONIDINE HCL 61 61 37 85
TERAZOSIN HCL 57 53 38 108
DOXAZOSIN MESYLATE 57 56 38 74
DILT-XR 56 55 40 317
NORTRIPTYLINE HCL 55 55 41 136
CITALOPRAM HBR 55 46 41 15
CLOPIDOGREL 54 45 43 50
CARBIDOPA-LEVODOPA 52 52 44 86
QVAR 51 38 45 167
DIGOXIN 51 50 45 41
LANTUS 50 41 47 37
TIZANIDINE HCL 50 50 47 176
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.